40.37
2.75%
-1.14
시간 외 거래:
40.37
Azenta Inc 주식(AZTA)의 최신 뉴스
Azenta (NASDAQ:AZTA) Sets New 1-Year LowHere's Why - MarketBeat
Azenta, Inc. (NASDAQ:AZTA) Sees Significant Drop in Short Interest - MarketBeat
Analysts Have Just Cut Their Azenta, Inc. (NASDAQ:AZTA) Revenue Estimates By 14% - Simply Wall St
Azenta, Inc. (NASDAQ:AZTA) Analysts Just Slashed This Year's Revenue Estimates By 14% - Yahoo Finance
Azenta, Inc. (NASDAQ:AZTA) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Yahoo Finance
Royce & Associates LP Increases Position in Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Azenta to Participate in Stephens Annual Investment Conference - StreetInsider.com
Azenta Inc (AZTA) Trading Down 3.84% on Nov 14 - GuruFocus.com
Azenta shares target trimmed by Evercore ISI amid challenging macro - Investing.com India
Shareholders Should Be Pleased With Azenta, Inc.'s (NASDAQ:AZTA) Price - Simply Wall St
Kayne Anderson Rudnick Investment Management LLC's Strategic Red - GuruFocus.com
Biobanking Market to Reach Market Valuation of USD 95.5 Billion by 2031 | SkyQuest Technology - GlobeNewswire Inc.
Azenta (NASDAQ:AZTA) Posts Earnings Results, Beats Expectations By $0.08 EPS - MarketBeat
Needham & Company LLC Cuts Azenta (NASDAQ:AZTA) Price Target to $55.00 - MarketBeat
Azenta, Inc. (NASDAQ:AZTA) Q4 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Azenta reports mixed FY 2024 results, plans B Medical sale - Investing.com UK
Azenta (AZTA) Q4 Earnings Top Estimates - MSN
Azenta Inc (AZTA) Q4 2024 Earnings Call Highlights: Navigating M - GuruFocus.com
Azenta Inc (AZTA) Q4 2024 Earnings Call Highlights: Navigating Market Challenges with Strategic ... - Yahoo Finance
Azenta, Inc. Reveals Strategic Portfolio Streamlining - TipRanks
Azenta, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended September 30, 2024 - Marketscreener.com
Azenta Appoints New CFO Amid Revenue Growth - TipRanks
Azenta Inc (AZTA) Q4 2024 Earnings: Revenue at $170M Beats Estimates, Reports GAAP EPS Loss of $0.10 - GuruFocus.com
Azenta reports modest growth and portfolio streamlining By Investing.com - Investing.com Australia
Brooks: Fiscal Q4 Earnings Snapshot - Marketscreener.com
Azenta reports modest growth and portfolio streamlining - Investing.com India
Azenta, Inc. Announces Chief Financial Officer Changes - Marketscreener.com
WCM Investment Management LLC Cuts Stock Holdings in Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
A Look Ahead: Azenta's Earnings Forecast - Benzinga
Azenta’s Cooperation Agreement with Politan Capital - Global Legal Chronicle
Azenta (NASDAQ:AZTA) versus OriginClear (OTCMKTS:OCLN) Critical Analysis - Defense World
Hudson Value Partners LLC Sells 39,671 Shares of Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Kirkland Advises Azenta on Cooperation Agreement with Politan Capital - Legal Desire News Network
Azenta (AZTA) Set to Announce Quarterly Earnings on Tuesday - MarketBeat
Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and Webcast - StreetInsider.com
Azenta (NASDAQ:AZTA) Shares Gap UpStill a Buy? - MarketBeat
Azenta Inc (AZTA) Stock Price Up 9.28% on Nov 4 - GuruFocus.com
Azenta Enhances Board and Reaffirms Growth Strategy - TipRanks
Azenta Enters into Cooperation Agreement with Politan Capital - Marketscreener.com
AZTAAzenta, Inc. Latest Stock News & Market Updates - StockTitan
Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive Value - StockTitan
Azenta Appoints Three Directors - citybiz
Raymond James & Associates Sells 33,843 Shares of Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Azenta, Inc. (NASDAQ:AZTA) Holdings Reduced by Conestoga Capital Advisors LLC - MarketBeat
Dimensional Fund Advisors LP Expands Portfolio with Azenta Inc A - GuruFocus.com
Azenta launches first approved long-read WGS test in US - Investing.com India
Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test - WV News
Azenta Announces Fiscal 2024 Third Quarter Earnings Conference C - GuruFocus.com
Genewiz From Azenta Life Sciences Celebrates 25 Years Of Advancing Scientific Discoveries At Genewiz Week Event - MSN
Azenta to Participate in the UBS MedTech, Tools and Genomics Sum - GuruFocus.com
Azenta (NASDAQ:AZTA) Sets New 52-Week LowHere's Why - MarketBeat
Allspring Global Investments Holdings LLC Buys 183,040 Shares of Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Azenta's CFO Herman Cueto sells shares worth $69,669 By Investing.com - Investing.com South Africa
Azenta, Inc. (NASDAQ:AZTA) CFO Sells $69,669.60 in Stock - MarketBeat
Azenta's CFO Herman Cueto sells shares worth $69,669 - Investing.com
자본화:
|
볼륨(24시간):